Streetbeat News

Regulatory

NBIX

Neurocrine Biosciences' Crinecerfont has received Priority Review from the FDA for the treatment of classic congenital adrenal hyperplasia (CAH). The FDA decision is expected by the end of 2024. If approved, Crinecerfont would be the first new treatment for CAH in 70 years and a first-in-class therapy.

Portfolio Pulse from Benzinga Newsdesk

July 01, 2024 | 11:37 am

VALN

Valneva shares are trading higher after the company received marketing authorization in Europe for its Chikungunya vaccine, IXCHIQ.

Portfolio Pulse from Benzinga Newsdesk

July 01, 2024 | 11:24 am

TSLA

Tesla Inc. (NASDAQ:TSLA) has filed a patent for an automatic sanitization system for vehicle cabins, which could be a key feature in its upcoming robotaxi service. The patent involves using sensors to detect environmental conditions and generate sanitization routines. This development is seen as a step towards Tesla's robotaxi launch, which could be a significant catalyst for the company's valuation.

Portfolio Pulse from Anan Ashraf

July 01, 2024 | 11:15 am

AEE

Ameren Missouri, a subsidiary of Ameren Corporation (NYSE:AEE), has filed a request with the Missouri Public Service Commission to adjust its electric base rates by mid-2025. The rate increase aims to fund major electric system upgrades and cleaner energy investments. If approved, the average residential customer would see an increase of about $17 per month.

Portfolio Pulse from Benzinga Newsdesk

July 01, 2024 | 10:56 am

HOLI

Ascendent Capital Partners, through its affiliate Superior Technologies, has received PRC approvals to complete its merger with Hollysys Automation Technologies.

Portfolio Pulse from Benzinga Newsdesk

July 01, 2024 | 10:53 am

VALN

The European Commission has granted marketing authorization for Valneva's single-dose vaccine, Ixchiq, for individuals 18 years and older. The company expects to deliver the first doses in Europe in Q4 of 2024.

Portfolio Pulse from Benzinga Newsdesk

July 01, 2024 | 10:40 am

OLN

WLK

Olin Corporation and Westlake Corporation, as part of the Ad Hoc Coalition of Epoxy Resin Producers, have prompted the European Commission to initiate an anti-dumping investigation on epoxy resin imports from China, Korea, Taiwan, and Thailand. The investigation aims to determine if these imports have caused material injury to the European epoxy resin industry by being sold at unfairly low prices.

Portfolio Pulse from Benzinga Newsdesk

July 01, 2024 | 10:35 am

SWTX

SpringWorks Therapeutics has submitted a New Drug Application to the FDA for mirdametinib, targeting pediatric and adult patients with Neurofibromatosis Type 1-Associated Plexiform Neurofibromas. The company also plans to file a Marketing Authorization Application with the European Medicines Agency in the second half of 2024.

Portfolio Pulse from Benzinga Newsdesk

July 01, 2024 | 10:32 am

ALK

BA

ITA

PPA

The U.S. Justice Department is moving to charge Boeing Co (NYSE:BA) over two fatal 737 MAX crashes, offering a plea deal with a substantial financial penalty and an independent monitor. If Boeing declines, it will face trial. The plea deal includes a $487.2 million penalty, potential restitution, and a three-year probation period. Boeing's ability to secure government contracts could be jeopardized. The news follows recent safety concerns and criticisms of Boeing's safety record.

Portfolio Pulse from Shivani Kumaresan

July 01, 2024 | 10:24 am

BA

LMT

Delays at United Launch Alliance (ULA), owned by Boeing and Lockheed Martin, have drawn military scrutiny. ULA, once a dominant rocket maker, is now trying to catch up to SpaceX.

Portfolio Pulse from Benzinga Newsdesk

July 01, 2024 | 10:23 am